On June 14, 2022 Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, reported that the management team will participate in and attend one-on-one meetings at three investor conferences in June 2022 as follows (Press release, Gracell Biotechnologies, JUN 14, 2022, View Source [SID1234615987]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Goldman Sachs Virtual Healthcare Corporate Day
One-on-one meetings: June 20 – 24
Truist Securities Cell Therapy Symposium – symposia-cel (in person)
One-on-one meetings: June 28
Location: New York, NY
Stifel 2022 Virtual Cell Therapy Summit
Panel: June 30 at 11:30 am ET
Corporate Panel: Allogeneic CAR-T – What Have We Learned, and Where are We Going